Our Services

AFSER is a channel partner for the sale of Prescience in silico Solution Suite PRinS3® developed by Prescience In silico Pvt. Ltd.

Prescience Insilico Pvt. Ltd. (PIPL) is working on developing software products and solutions in the areas of integrating artificial intelligence (AI), high-throughput computing, cloud computing with physics-based computational methods in drug and materials design/development. PIPL has successfully developed its own indigenous software platform PRinS3 to enable the pharmaceutical industry and academic R&D to perform high-throughput screening, structure-based modeling, and simulations by incorporating AI and cloud computing for designing/repurposing drug molecules for different therapeutics. This is the first such software platform indigenously built in India. This software platform is designed to solve the problems in drug design by 1. Shortening the duration of time to design a potential drug molecule, 2. Cost of the drug development cycle, 3. Specificity of the potential drug to the target disease to reduce failure.-

The company is founded by Prof. Jayant K Sing (IIT Kanpur Professor in Chemical Engineering, former GM Scientist, IIT Kanpur Graduate, Ph.D. Uni. of Buffalo - with 23+ years of experience in Computer Science and Chemical Engineering modeling) and Dr. Sudip Roy (former CSIR-NCL, Pune Scientist, former Shell Senior Scientist, former VP/R&D head Akamara Biomedicine, former Intel Tech Manager, former Amazon Web Services Head HPC and Quantum Computing, Ph.D. University of Saarland, Germany – 22+ years of experience in scientific computing, AI/ML, and high-performance computing).

Key Features of the Software:

1. Artificial Intelligence-Based New Chemical Design
2. High Throughput Screening of Multiple Target and Multiple Ligands using Docking and Free Energy
3. Cloud-enabled platform for high throughput Screening
4. Protein Modelling and preparation

Also AFSER is rendering its services for paid project work on PRinS3 ., Drug Design Software for Thesis and Projects of Postgraduate/ Doctorate students and commercial projects in Drug Discovery.

Please fill this Google Form to know more

Further Contact: https://www.prescience.in/contact-us
+918080496640

AFSER is playing a dominant role in philanthropic education services. The biggest task that AFSER performed during COVID-19 phase was moral building and engaging the people for their educational needs. Please visit the Annual Report page for more information.

AFSER serves the worldwide youth training and philanthropic education through quality and affordable online courses mainly in science. Please visit the link:

Current Trends in Pharmacy and Pharmaceutical Chemistry is the official Journal of Ateos Foundation of Science Education and Research, hosted and Managed IP Innovative Publications Pvt. Ltd, New Delhi, India. e-ISSN: 2582-5062 Current Trends in Pharmacy and Pharmaceutical Chemistry open access, peer-reviewed quarterly international journal publishing since 2019 and is published under auspices of the Ateos Foundation of Science Education and Research, aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. With the aim of faster and better dissemination of knowledge, we will be publishing the article ‘Ahead of Print’ immediately on acceptance. In addition, the journal would allow free access (Open Access) to its contents, which is likely to attract more readers and citations to articles published in CTPPC. Manuscripts must be prepared in accordance with “Uniform requirements for Manuscripts submitted to Biomedical Journals” as per guidelines by the International Committee of Medical Journals Editors (Updated December 2019). The uniform requirements and specific requirements of CTPPC are mentioned below. Before sending a manuscript contributors are requested to check for the author guidelines are available from the website of the journal (https://www.ctppc.org/info/author) or directly from (Innovative Pre-Publication Portal) manuscript submission website https://innovpub.org/journal/CTPPC The aim and commitment of the journal are to publish a research-oriented manuscript address significant issues in all the subjects and areas of Pharmacy and Pharmacology. Journal is committed itself to improve Education and Research on Clinical Pharmacology, clinical trials, clinical pharmacology, drug delivery, experimental pharmacy, experimental trial, pharmacology, pharmacy practice, pharmacy education, etc.

Indexing and Abstracting Information
Google Scholar, Indian Science Abstracts, National Science Library, J- gate, ROAD, CrossRef, Microsoft Academic, Indian Citation Index (ICI). Journal is committed to upholding the highest standards of ethical behavior at all stages of publication. We strictly adhere to the industry associations such as the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICMJE), and World Association of Medical Editors (WAME), that set standards and provide guidelines for best practices in order to meet these requirements. Our specific policies regarding duplicate publication, conflict of interest, patient consent, etc., Please visit the editor guidelines

Click on to www.ctppc.org